Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey

Abstract

BackgroundUnderstanding and addressing treatment abandonment (TxA) is crucial for bridging the pediatric cancer survival gap between high-income (HIC) and low-and middle-income countries (LMC). In childhood cancer, TxA is defined as failure to start or complete curative cancer therapy and known to be a complex phenomenon. With rising interest on causes and consequences of TxA in LMC, this study aimed to establish the lay-of-the-land regarding determinants of TxA globally, perform and promote comparative research, and raise awareness on this subject.MethodsPhysicians (medical oncologists, surgeons, and radiation therapists), nurses, social workers, and psychologists involved in care of children with cancer were approached through an online survey February-May 2012. Queries addressed social, economic, and treatment-related determinants of TxA. Free-text comments were collected. Descriptive and qualitative analyses were performed. Appraisal of overall frequency, burden, and predictors of TxA has been reported separately.Results581 responses from 101 countries were obtained (contact rate = 26%, cooperation rate = 70%). Most respondents were physicians (86%), practicing pediatric hematology/oncology (86%) for >10 years (54%). Providers from LMC considered social/economic factors (families’ low socioeconomic status, low education, and long travel time), as most influential in increasing risk of TxA. Treatment-related considerations such as preference for complementary and alternative medicine and concerns about treatment adverse effects and toxicity, were perceived to play an important role in both LMC and HIC. Perceived prognosis seemed to mediate the role of other determinants such as diagnosis and treatment phase on TxA risk. For example, high-risk of TxA was most frequently reported when prognosis clearly worsened (i.e. lack of response to therapy, relapse), or conversely when the patient appeared improved (i.e. induction completed, mass removed), as well as before aggressive/mutilating surgery. Provider responses allowed development of an expanded conceptual model of determinants of TxA; one which illustrates established and emerging individual, family, center, and context specific factors to be considered in order to tackle this problem. Emerging factors included vulnerability, family dynamics, perceptions, center capacity, public awareness, and governmental healthcare financing, among others.ConclusionTxA is a complex and multifactorial phenomenon. With increased recognition of the role of TxA on global pediatric cancer outcomes, factors beyond social/economic status and beliefs have emerged. Our results provide insights regarding the role of established determinants of TxA in different geographical and economic contexts, allow probing of key determinants by deliberating their mechanisms, and allow building an expanded conceptual model of established and emerging determinants TxA.

Holistic support coupled with prospective tracking reduces abandonment in childhood cancers: A report from India

“…It is estimated that LMICs account for 99% of TxA worldwide, which in turn might account for at least a third of the survival gap between HICs and LMICs . Determinants of TxA in our study (socioeconomic factors, perceived prognosis of disease, concerns about toxicity, and preference for TCAM) are very similar to those worldwide, as established in a global online survey, a systematic review, and other reports . Strategies to reduce abandonment are being studied and increasingly reported .…”

Disparities in the delivery of pediatric oncology nursing care by country income classification: International survey results

“…This has critical implications in L/LMIC, where toxicity‐related deaths and treatment abandonment are disproportionately high. Factors such as parental socioeconomic status, literacy, and beliefs about cancer are determinants of treatment abandonment in low‐resource settings, which highlights the need for education and reinforcement of treatment goals in these settings …”

Health‐care providers’ perspectives on traditional and complementary alternative medicine of childhood cancer in Kenya

“…Although childhood cancer survival in high‐income countries may be around 80%, cure rates are usually less than 10% in low‐income countries . An important reason for this poor survival is nonadherence with conventional medicine . This nonadherence may be partially caused by parental disbelief in curability of childhood cancer and preference for TCAM .…”